Discover 3,069 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,069
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase3, Recruiting
A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
for
AML, MDS
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: TScan Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07702578
Phase3, Recruiting
Resilience and Equity in Aging, Cancer, and Health (REACH)
Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)
for
Nicotine Dependence, Transcranial Magnetic Stimulation, Vaping,
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 65
Code: NCT07145866
Recruiting
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
for
Non Hodgkin Lymphoma, Richter Transformation, Multiple Myeloma,
Location: Boston MA, Chapel Hill NC, Columbus OH, Cincinnati OH,
Sponsor: Newave Pharmaceutical Inc
Sex: All
Age: 13+
Code: NCT04771572
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Towards Testing the Effectiveness of Recovery Community Centers (RCCs)
for
Opioid Use Disorder
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT07010978
Recruiting
Stress Dynamics and Familial Risk for Depression in Female Adolescents
for
Major Depressive Disorder
Location: Belmont MA
Sponsor: Mclean Hospital
Sex: Female
Age: 13 - 15
Code: NCT06816329
Recruiting
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
for
HEPATITIS B CHRONIC
Location: Boston MA
Sponsor: Precision BioSciences, Inc.
Sex: All
Age: 18 - 70
Code: NCT06680232
Phase1, Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Location: Boston MA, New York NY, Ann Arbor MI, Nashville TN,
Sponsor: Remix Therapeutics
Sex: All
Age: 18+
Code: NCT06118086
Phase1, Phase2, Recruiting
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Boston MA, New York NY, Philadelphia PA, Detroit MI,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT04590326
Phase1, Phase2, Recruiting
Cognitive Rehabilitation for Victims of War and Related Traumas With Traumatic Brain Injury and Cognitive Impairment
for
TBI (Traumatic Brain Injury), Cognitive Symptoms
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 65
Code: NCT06839079
Recruiting
Suprachoroidal Administration in Subjects With Metastases to the Choroid
for
Eye Cancer, Primary Cancer
Location: Boston MA, Ann Arbor MI, Nashville TN, Miami FL,
Sponsor: Aura Biosciences
Sex: All
Age: 18+
Code: NCT06643884
Phase2, Recruiting
Study of COYA 302 for the Treatment of ALS
for
Amyotrophic Lateral Sclerosis (ALS)
Location: Boston MA, New York NY, Philadelphia PA, Montreal,
Sponsor: Coya Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07161999
Phase2, Phase3, Recruiting
A Study of LY4175408 in Participants With Advanced Cancer
for
Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma,
Location: Boston MA, New York NY, Hackensack NJ, Fairfax VA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07046923
Phase1, Recruiting
Web-based Mind-body Program to Improve Resilience Among Risky Substance Users With Persistent Upper Extremity Pain